Cargando…
Sofosbuvir (SOF) Suppresses Ledipasvir (LDV)-resistant Mutants during SOF/LDV Combination Therapy against Genotype 1b Hepatitis C Virus (HCV)
Our objective was to identify drug interactions between ledipasvir (LDV) and sofosbuvir (SOF) against a genotype 1b replicon to determine optimal exposures for each agent that will maximize antiviral activity against susceptible and drug-resistant subpopulations. LDV and SOF were evaluated using a f...
Autores principales: | Brown, Ashley N., Liu, Lin, Rodriquez, Jaime L., Zhao, Lisa, Schuster, Layla, Li, Eric, Wang, Gary P., Neely, Michael N., Yamada, Walter, Drusano, George L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5663921/ https://www.ncbi.nlm.nih.gov/pubmed/29089577 http://dx.doi.org/10.1038/s41598-017-15007-2 |
Ejemplares similares
-
Real-world Effectiveness of Ledipasvir/Sofosbuvir (LDV/SOF) for 8 weeks in Patients Coinfected with HCV and HIV-1
por: Ruane, Peter, et al.
Publicado: (2017) -
The levels of monoamine neurotransmitters and measures of mental and emotional health in HCV patients treated with ledipasvir (LDV) and sofosbuvir (SOF) with or without ribavirin (RBV)
por: Golabi, Pegah, et al.
Publicado: (2016) -
Lactate dehydrogenase-elevating virus (LDV): subgenomic mRNAs, mRNA leader and comparison of 3'-terminal sequences of two LDV isolates
por: Lili, Kuo, et al.
Publicado: (1992) -
EURISOL-DS METEX1: LDV measurement to detect Cavitations
por: Lettry, Jacques, et al.
Publicado: (27/1) -
Complete Genomic Sequence and Phylogenetic Analysis of the Lactate Dehydrogenase-Elevating Virus (LDV)
por: Godeny, E.K., et al.
Publicado: (1993)